Claus Hellerbrand
University of Regensburg
Department of Internal Medicine I
D-93042 Regensburg
Germany
Name/email consistency: high
- The novel gene MIA2 acts as a tumour suppressor in hepatocellular carcinoma. Hellerbrand, C., Amann, T., Schlegel, J., Wild, P., Bataille, F., Spruss, T., Hartmann, A., Bosserhoff, A.K. Gut (2008)
- Reduced expression of CYLD in human colon and hepatocellular carcinomas. Hellerbrand, C., Bumes, E., Bataille, F., Dietmaier, W., Massoumi, R., Bosserhoff, A.K. Carcinogenesis (2007)
- HFE C282Y heterozygosity in hepatocellular carcinoma: evidence for an increased prevalence. Hellerbrand, C., Pöppl, A., Hartmann, A., Schölmerich, J., Lock, G. Clin. Gastroenterol. Hepatol. (2003)
- Mutation analysis of the HFE gene in German hemochromatosis patients and controls using automated SSCP-based capillary electrophoresis and a new PCR-ELISA technique. Hellerbrand, C., Bosserhoff, A.K., Seegers, S., Lingner, G., Wrede, C., Lock, G., Schölmerich, J., Büttner, R. Scand. J. Gastroenterol. (2001)
- Hepatocellular carcinoma in southern Germany: epidemiological and clinicopathological characteristics and risk factors. Hellerbrand, C., Hartmann, A., Richter, G., Knöll, A., Wiest, R., Schölmerich, J., Lock, G. Dig. Dis (2001)